INS and Hyperglycemia: Even a lower dose of genistein (250 mg/kg for 4 weeks) ameliorated hyperglycemia, glucose tolerance, and insulin levels in STZ-induced diabetic mice, which was accompanied by improved β-cell proliferation, survival, and mass [101].